We could not find any results for:
Make sure your spelling is correct or try broadening your search.
New Patent is Added to the Company’s Portfolio of Formulations that Rapidly Reduce Blood Alcohol Content JUPITER, Fla., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT...
JUPITER, FL, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (the “Company” or “Safety Shot”) is pleased to announce that Safety Shot President Jordan Schur has invested in a...
As Masters in the E-Commerce Space VENDO is Anticipated to Significantly Help to Grow the Safety Shot Brand Online. JUPITER, Fla., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq:...
- Q2 Revenues Increased 40%- Q2 Operating Expenses Decreased 17.7%- Recent Clinical Trial Confirms Dramatic Reduction of Blood Alcohol Content- Revolutionary Formula to be Soon Released in...
First-of-its-kind wellness company Safety Shot announces clinical trials solidifying the brand’s dietary supplement’s ability to significantly reduce Blood Alcohol Content JUPITER, FL, Aug. 12...
With an Expected Launch in Early Q4, Safety Shot Powder Stick Packets Will Address an Anticipated $517M Market Size JUPITER, Fla., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq:...
The Partnership Will Greatly Expand Market Reach for Safety Shot to Meet Increased Demand and a Broader Consumer Audience JUPITER, FL, July 15, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.14 | 77.7777777778 | 0.18 | 0.5 | 0.1191 | 3223 | 0.21888846 | CS |
4 | 0.07 | 28 | 0.25 | 0.5 | 0.105 | 2631 | 0.21284764 | CS |
12 | -0.0012 | -0.373599003736 | 0.3212 | 0.666 | 0.105 | 2946 | 0.29617255 | CS |
26 | -0.1 | -23.8095238095 | 0.42 | 3 | 0.0512 | 7022 | 1.10835726 | CS |
52 | -0.1 | -23.8095238095 | 0.42 | 3 | 0.0512 | 7022 | 1.10835726 | CS |
156 | -0.1 | -23.8095238095 | 0.42 | 3 | 0.0512 | 7022 | 1.10835726 | CS |
260 | 0 | 0 | 0 | 0.5 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions